A blocking CCR2 monoclonal antibody and/or neutralizing CCL7 antibodies abolish some of the pro-migration effects of conditioned medium from BM stromal cells on MM (Vande Broek et al., 2003). The gene discussed is CCR2; the disease is Miyoshi myopathy.